The Cholesterol Bet
Taking lessons from a failed drug, firms are ready to test a heart health hypothesis
Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2024 American Chemical Society
February 20, 2012 Cover
Volume 90, Issue 8
Taking lessons from a failed drug, firms are ready to test a heart health hypothesis
Cover image:
Credit:
Pharmaceuticals
A Dual-Use Debate
In light of controversial H5N1 bird flu experiments, experts hashed out myriad issues at a public forum in New York City
Materials Data For The Masses
Public portals to computed data and search tools are set to accelerate the pace of materials discovery
-
The Quantum Side of Photosynthesis
Coherent waves may enhance energy transfer
-
Merger Momentum Abates
After a brisk first quarter, big spending on chemical acquisitions slowed in 2011
-
Jody Roberts
The science historian discovers flaws in original design and implementation of much-debated Toxic Substances Control Act
ADVERTISEMENT
Science Concentrates
3-D View Inside A Battery
MRI method generates diagnostic images that reveal normally hidden details of electrodes and electrolytes
